Tag: medications

Business

WSJ News Exclusive | Novartis in Advanced Talks to Buy Cytokinetics

January 8, 2024
Henry

Novartis is close to clinching an acquisition of Cytokinetics and its promising heart drug, as pharmaceutical…

World News

Johnson & Johnson to Acquire Cancer-Treatment Developer Amrbx for $2B

January 8, 2024
Henry

Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal. The…

Business

Johnson & Johnson to Acquire Cancer-Treatment Developer Amrbx for $2 Billion

January 8, 2024
Henry

Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal. The…

Business

A Tale of Two Pharmas: Can Obesity Firms Continue Their Outperformance in 2024?

December 27, 2023
Henry

In pharma, you can take a larger slice of the healthcare pie than your peers, but…

Business

Wegovy Maker Novo Nordisk to Spend $6 Billion Boosting Production Capacity

November 10, 2023
Henry

Novo Nordisk, the Danish pharmaceutical giant that makes the blockbuster Wegovy obesity drug, said it will…

Business

Obesity Drug Demand Outstrips Supply

November 2, 2023
Henry

Eli Lilly’s blockbuster diabetes medication Mounjaro is expected to receive Food and Drug Administration approval as…

World News

GSK PLC Raises Guidance After RSV Vaccine Lifts Earnings

November 1, 2023
Henry

Updated Nov. 1, 2023 4:08 am ET GSK PLC raised its guidance after third-quarter net profit…

Business

‘Guided Missile Drugs’ Could Be Big Pharma’s Secret Weapon

October 26, 2023
Henry

Merck and Pfizer are the latest big pharma companies to invest in this booming area.

World News

Health Care Roundup: Market Talk

October 26, 2023
Henry

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at…

Business

WSJ News Exclusive | CVS Pulls Certain Cold Medicines From Shelves and Will Stop Selling Them

October 20, 2023
Henry

Updated Oct. 20, 2023 11:00 am ET CVS Health is pulling some of the most common…